SGS Poitiers Lab Receives GMP Certification - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

SGS Poitiers Lab Receives GMP Certification


SGS Life Science Services announced that its bioanalytical laboratory in Poitiers, France has received GMP certification, following approval from the Agence Nationale de Sécurité du Médicaments et des Produits de Santé (ANSM), the French agency charged with ensuring the quality of drug products. With this GMP certification, the laboratory can provide tests required for final batch release, the company reports in a press statement.

The GMP services will be performed in dedicated suites and controlled access areas of 200 square meters. The facility has been operating under GLP since 1994. With the Life Science Services laboratory in Clichy, France, the company provides services covering GMP activities for small and large molecules.

By bringing GMP to the Poitiers site, the company can offer cell-based assays for testing of biologics, including biosimilars. The company plans to bring bioanalytical capability to the West Coast of North America with a new facility in Carson, Cailf.

Source: SGS

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
30%
Breakthrough designations
10%
Protecting the supply chain
40%
Expedited reviews of drug submissions
10%
More stakeholder involvement
10%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests

Click here